Alumni

BSE: Annual Environment Public Lecture

admin — Mon, 17 Feb 2025 18:09:53 +0000

The Bieler School of Environment's Annual Environment Lecture, featuring Dr. Britt Wray.

Dr. Wray, the mind behind the national bestseller Generation Dread: Finding Purpose in an Age of Climate Anxiety, will share her passionate insights on how we can maintain our mental health while tackling the climate crisis. Her book has captivated readers and was shortlisted for the Governor General’s Award.

2025 Hughlings Jackson Lecture: The Basal Ganglia and the Motivation to Act

admin — Mon, 13 Jan 2025 21:40:52 +0000

Established in 1935, the Hughlings Jackson Lecture is The Neuro’s premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the development of neurology as a medical specialty.

Albert Aguayo Lecture: Unlocking Secrets in Nerve Repair: From Neuronal Signaling to Glial Modulation

admin — Mon, 20 Jan 2025 15:27:51 +0000

This annual lecture honours Dr. Albert Aguayo, OC, FRCP, Professor Emeritus founder and former Director of the Centre for the Research in Neuroscience at ��ϲ�� University. A cocktail reception will follow the lecture.

2025 Neuro Epilepsy Day and Pierre Gloor Lecture

admin — Tue, 03 Dec 2024 14:37:05 +0000

The Neuro Epilepsy Day is a half-day event. The day will focus on neurodegeration and tauopathy in epilepsy, and its implications for cognition and disease progression.

8th National Neuromuscular Review Course

admin — Thu, 13 Feb 2025 16:08:29 +0000

Dr. Nicolas Dupré of Laval University, Dr. Karine Garneau of Université de Montréal, and the members of the organizing committee are pleased to announce the 8th National Neuromuscular Review Course.

26th Annual Neuropsychology Day and Brenda Milner Lecture

admin — Thu, 09 Jan 2025 15:31:44 +0000

The 26th Annual Neuropsychology Day and Brenda Milner Lecture honours the career and achievements of Professor Brenda Milner, an eminent cognitive neuroscientist and pioneer of the discipline of neuropsychology.

At-home neurological disorder diagnosis project receives major funding

admin — Fri, 08 Nov 2024 18:24:33 +0000

$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson’s disease

REM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What’s worse, people with the disorder often go on to develop Parkinson’s disease.

AI analysis of healthcare records reveals key factors in autism diagnosis

admin — Wed, 26 Mar 2025 15:23:21 +0000

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

admin — Fri, 14 Mar 2025 13:09:39 +0000

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.

Open Science project funded for $1.5M

admin — Tue, 12 Nov 2024 16:51:24 +0000

YCharOS antibody characterization platform addresses the “reproducibility crisis” in research

An innovative research project led by researchers at The Neuro has been awarded $1.5M by the Government of Quebec through CQDM.

YCharOS is an innovative platform led by neuroscientists Peter McPherson and Carl Laflamme that validates antibody reagents for human proteins.

Project to create AI model for ALS receives Génome Québec funding

admin — Mon, 17 Mar 2025 15:29:17 +0000

$400,000 will fuel public-private collaboration to discover new disease biomarkers

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

Six principal investigators from The Neuro receive CIHR grants

admin — Mon, 10 Feb 2025 18:44:57 +0000

Projects include important research on Parkinson’s, glioblastoma and dementia

Genetic sequencing project receives more than $8 million in funding

admin — Tue, 18 Mar 2025 14:55:14 +0000

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of ��ϲ�� University and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

An open solution to improving research reproducibility

admin — Wed, 18 Dec 2024 16:12:19 +0000

Academic and industry scientists collaborate on a new method to characterize research antibodies

Latest Alzheimer’s drug shown less effective in females than males

admin — Tue, 18 Mar 2025 18:27:46 +0000

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.